ImageneBio, Inc. SEC filings IMA
ImageneBio, Inc. has 336 filings in SEC EDGAR's recent list, going back to Jan 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 23, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 13, 2026 | Apr 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 17, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 19, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2025 | Nov 1, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Oct 29, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2025 | Oct 10, 2025 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Aug 12, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Auditor change
|
Aug 5, 2025 | Aug 2, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 1, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 29, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Other events
|
Jul 22, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 16, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jul 15, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Other events
|
Jul 11, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 1, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 12, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
May 28, 2024 | May 23, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 21, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Regulation FD disclosure, Other events
|
Jan 18, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Oct 11, 2023 | Oct 11, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 7, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Listing notice
|
Jun 30, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 17, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 28, 2022 | Nov 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Other events
|
Apr 6, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2022 | Jan 28, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 26, 2022 | Jan 21, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2021 | Apr 15, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Mar 30, 2021 | Mar 25, 2021 |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1835579
- Former names
- Ikena Oncology, Inc. (until Jul 25, 2025)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.